|
聚苯丙生市场分析报告
|
Global Market Report of Polifeprosan (CAS 90409-78-2) December 2024
Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major glioma markets reached a value of US$ 1.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.6 Billion by 2034, exhibiting a growth rate (CAGR) of 3.83% during 2024-2034. The glioma market has been comprehensively ...
High-Grade Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major high-grade glioma markets are expected to exhibit a CAGR of 3.45% during 2024-2034. The high-grade glioma market has been comprehensively analyzed in IMARC's new report titled "High-Grade Glioma Market: Epidemiology, Industry Trends, Share, ...
Recurrent Glioblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major recurrent glioblastoma markets are expected to exhibit a CAGR of 5.85% during 2024-2034. The recurrent glioblastoma market has been comprehensively analyzed in IMARC's new report titled "Recurrent Glioblastoma Market: Epidemiology, Industry ...
|
|
|